CML is a myeloproliferative disease characterized by the presence of the Philadelphia chromosome, involving a translocation between chromosomes 9 and 22 producing the bcr-abl fusion protein and exhibiting constitutive tyrosine kinase signaling activity. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.